2023 Annual Meeting | S7 - Outcome Measures and Observational Studies of Neuromuscular Diseases
Program Materials Program Evaluations
| Stefan Nicolau, MD | The institution of Dr. Nicolau has received research support from Muscular Dystrophy association. The institution of Dr. Nicolau has received research support from American Brain Foundation. The institution of Dr. Nicolau has received research support from American Neuromuscular Foundation. |
| Nicolas Sarmiento Bustamante | Mr. Sarmiento Bustamante has nothing to disclose. |
| Samantha Jo LoRusso, MD | Dr. LoRusso has nothing to disclose. |
| Andrea Jaworek, PT | Dr. Jaworek has nothing to disclose. |
| Leann Lewis | Leann Lewis has nothing to disclose. |
| Teerin Liewluck, MD, FAAN | Dr. Liewluck has nothing to disclose. |
| Doris G. Leung, MD | The institution of Dr. Leung has received research support from US Department of Defense. The institution of Dr. Leung has received research support from Fulcrum Therapeutics. The institution of Dr. Leung has received research support from ML Bio Solutions, Inc.. The institution of Dr. Leung has received research support from Sarepta Therapeutics. The institution of Dr. Leung has received research support from Cumberland Pharmaceuticals. The institution of Dr. Leung has received research support from FibroGen Inc.. The institution of Dr. Leung has received research support from Astellas Pharma. The institution of Dr. Leung has received research support from University of Kansas Medical Center Research Institute. The institution of Dr. Leung has received research support from Pfizer, Inc.. The institution of Dr. Leung has received research support from Genethon. The institution of Dr. Leung has received research support from Harmony Biosciences. The institution of Dr. Leung has received research support from Edgewise Therapeutics. |
| Sabrina Sacconi, MD | Dr. Sacconi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for DYNE THERAPEUTICS. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LUPIN. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BIOGEN. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LFB. Dr. Sacconi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ROCHE. Dr. Sacconi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for SANOFI. Dr. Sacconi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. The institution of Dr. Sacconi has received research support from Solve FSHD. |
| Nicholas Elwood Johnson, MD, FAAN | Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta Therapuetics. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne Therapeutics. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex Pharma. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Triplet Therapuetics. Dr. Johnson has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for ML BIo . Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acceleron. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avidity. Dr. Johnson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Arthex. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Juvena. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Entrada. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Johnson has stock in ML Bio. The institution of Dr. Johnson has received research support from AveXis. The institution of Dr. Johnson has received research support from Fulcrum. The institution of Dr. Johnson has received research support from AMO Pharma. The institution of Dr. Johnson has received research support from Sarepta. The institution of Dr. Johnson has received research support from Dyne Therapeutics. The institution of Dr. Johnson has received research support from Vertex . The institution of Dr. Johnson has received research support from Triplet Therapeutics. The institution of Dr. Johnson has received research support from ML Bio. The institution of Dr. Johnson has received research support from Vertex. The institution of Dr. Johnson has received research support from Entrada . Dr. Johnson has received intellectual property interests from a discovery or technology relating to health care. |
| William Martens | William Martens has nothing to disclose. |
| Amelia Wilson, PT | Dr. Wilson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Casimir. Dr. Wilson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Avidity. |
| Leo Hong-Li Wang, MD, PhD, FAAN | Dr. Wang has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AskBio. Dr. Wang has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Fulcrum Therapeutics. Dr. Wang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Wang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Wang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Wang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avidity. Dr. Wang has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. The institution of Dr. Wang has received research support from National Institute of Health. Dr. Wang has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with US Government. |
| Joy Anne Kerr Stouffer | Ms. Stouffer has nothing to disclose. |
| Hanns Lochmuller, MD, FAAN | Dr. Lochmuller has nothing to disclose. |
| Jack K. Donohue | Mr. Donohue has nothing to disclose. |
| Bakri Elsheikh, MD, FAAN | Dr. Elsheikh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen . Dr. Elsheikh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argnex . The institution of Dr. Elsheikh has received research support from Biogen. The institution of Dr. Elsheikh has received research support from Cure SMA. |
| Nicol Voermans, MD | The institution of Mrs. Voermans has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dynacure. The institution of Mrs. Voermans has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. The institution of Mrs. Voermans has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neuromuscular disorder. |
| Akhilesh Pandey, MD,PhD | Dr. Pandey has nothing to disclose. |
| Matthew P. Wicklund, MD, FAAN | Dr. Wicklund has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus Therapeutics. Dr. Wicklund has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. Dr. Wicklund has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta Therapeutics. Dr. Wicklund has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Spark Therapeutics. Dr. Wicklund has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ultragenyx. Dr. Wicklund has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vertex Pharmaceuticals. The institution of Dr. Wicklund has received research support from Orphazyme. The institution of Dr. Wicklund has received research support from Muscular Dystrophy Association. The institution of Dr. Wicklund has received research support from Coalition to Cure Calpain 3. The institution of Dr. Wicklund has received research support from Sarepta Therapeutics. The institution of Dr. Wicklund has received research support from ML Bio. The institution of Dr. Wicklund has received research support from Alexion. The institution of Dr. Wicklund has received research support from Acceleron. The institution of Dr. Wicklund has received research support from Edgewise. The institution of Dr. Wicklund has received research support from Fulcrum. The institution of Dr. Wicklund has received research support from Roche-Genentech. The institution of Dr. Wicklund has received research support from Avidity. Dr. Wicklund has received research support from Harmony Bioscience. |
| Janice Pieretti, MD | Dr. Pieretti has nothing to disclose. |
| Chafic Y. Karam, MD | Dr. Karam has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alnylam. Dr. Karam has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Karam has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Karam has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Karam has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Karam has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuroderm. |
| Sami L. Khella, MD, FAAN | Dr. Khella has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ionis. Dr. Khella has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Khella has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Khella has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Khella has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eidos. |
| Russell Butterfield, MD, PhD, BS | Dr. Butterfield has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avexis. Dr. Butterfield has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Butterfield has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Butterfield has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. Dr. Butterfield has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aavanti Bio. Dr. Butterfield has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Reata. The institution of Dr. Butterfield has received research support from FSHD Society. The institution of Dr. Butterfield has received research support from NIH. The institution of Dr. Butterfield has received research support from Ionis. |
| Jeffrey Statland, MD | Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arrowhead. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ML Bio. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MT Pharma. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Epic Bio. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Armatus . Dr. Statland has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dyne Therapeutics. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity . Dr. Statland has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fulcrum Therapeutics. Dr. Statland has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Statland has received research support from NIH. The institution of Dr. Statland has received research support from FSHD Society. The institution of Dr. Statland has received research support from Friends of FSH Research. The institution of Dr. Statland has received research support from FSHD Canada. The institution of Dr. Statland has received research support from MDA. |
| Margo A. Peyton, MD | Dr. Peyton has nothing to disclose. |
| Melissa McIntyre | Melissa McIntyre has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Avidity Biosciences, Inc. Melissa McIntyre has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Casimir, LLC. Melissa McIntyre has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ATOM International Limited. |
| Kelly Marshall | Ms. Marshall has nothing to disclose. |
| Joost Kools, MD | The institution of Mr. Kools has received research support from Fulcrum Therapeutics. |
| Margherita Milone, MD, FAAN | Dr. Milone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Milone has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Genetics, AAN. The institution of Dr. Milone has received research support from Mayo Clinic, CCaTS-CBD. The institution of Dr. Milone has received research support from Mayo Clinic, SGP Award. The institution of Dr. Milone has received research support from MDA for Care Center grant. The institution of Dr. Milone has received research support from Regenerative medicine Minnesota. |
| Kameron Bates, Other | Mr. Bates has nothing to disclose. |
| Floranne Ernste | Floranne Ernste has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for The Myositis Association. The institution of Floranne Ernste has received research support from Octapharma. |
| Laura Flashman, PhD | Dr. Flashman has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Archives of Clinical Neuropsychology. The institution of Dr. Flashman has received research support from NIH/NINDS. The institution of Dr. Flashman has received research support from Michael J Fox Foundation. |
| Inherited Neuropathi Rare Disease Clinical Research | No disclosure on file |
| Michaela Walker, MPH, CCRP | Miss Walker has nothing to disclose. |
| Leroy R. Thacker, PhD | The institution of Dr. Thacker has received research support from NIH. |
| Michael Paul Skolka, MD | Dr. Skolka has nothing to disclose. |
| Charlotte J. Sumner, MD, FAAN | Dr. Sumner has received personal compensation for serving as an employee of Biogen. Dr. Sumner has received personal compensation for serving as an employee of Avexis. Dr. Sumner has received personal compensation for serving as an employee of Roche/Genentech. Dr. Sumner has received personal compensation for serving as an employee of Ionis Pharmaceuticals. Dr. Sumner has received personal compensation for serving as an employee of Sarepta. Dr. Sumner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Sumner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avexis/Novartis. Dr. Sumner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche/Genentech. Dr. Sumner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. Dr. Sumner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Sumner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Proneurotech. Dr. Sumner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CMTRF. Dr. Sumner has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal Clinical Investigation. Dr. Sumner has received research support from Roche. Dr. Sumner has received intellectual property interests from a discovery or technology relating to health care. Dr. Sumner has received publishing royalties from a publication relating to health care. |
| Brian Drachman | Brian Drachman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Brian Drachman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea. |
| Catherine Kieu, PT | Ms. Kieu has nothing to disclose. |
| Anil Tarachandani, PhD | Dr. Tarachandani has received personal compensation for serving as an employee of UsinLife LLC. |
| Surendra Dasari, PhD | Prof. Dasari has nothing to disclose. |
| Perry Shieh, MD, PhD, FAAN | Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta. Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for CSL Behring. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Grifols. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Shieh has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Biogen. Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Argenx. Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Catalyst. |
| Chad R. Heatwole, MD, FAAN | Dr. Heatwole has received personal compensation for serving as an employee of Legal Med. Dr. Heatwole has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Virginia Commonwealth University. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Harmony. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IRIS. Dr. Heatwole has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Recursion. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avidity. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pennsylvania Prop and Gas Ins. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Harmony. Dr. Heatwole has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for cytokinetics. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for scholar rock. Dr. Heatwole has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for neurocrine. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for swan bio. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. Dr. Heatwole has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Legal Med. The institution of Dr. Heatwole has received research support from NIH. The institution of Dr. Heatwole has received research support from Recursion. The institution of Dr. Heatwole has received research support from MDA. The institution of Dr. Heatwole has received research support from PPMD. The institution of Dr. Heatwole has received research support from FARA. The institution of Dr. Heatwole has received research support from Curesma. The institution of Dr. Heatwole has received research support from ALSA. The institution of Dr. Heatwole has received research support from Huntington Study Group. The institution of Dr. Heatwole has received research support from department of defence. The institution of Dr. Heatwole has received research support from swan bio. The institution of Dr. Heatwole has received research support from Parent project. Dr. Heatwole has received intellectual property interests from a discovery or technology relating to health care. |
| Brett Andrew McCray, MD | The institution of Dr. McCray has received research support from NIH. The institution of Dr. McCray has received research support from Johns Hopkins Merkin Peripheral Neuropathy and Nerve Regeneration Center. The institution of Dr. McCray has received research support from Muscular Dystrophy Association. |
| Elena Carraro, MD,FRACP | Dr. Carraro has nothing to disclose. |
| Amanda Catherine Butler, PT | Mrs. Butler has nothing to disclose. |
| Peggy C. Nopoulos, MD | The institution of Dr. Nopoulos has received personal compensation in the range of $500-$4,999 for serving as a Consultant for norvartis. |
| Megan McNerney Holzer, PT | Dr. Holzer has received personal compensation for serving as an employee of Kennedy Krieger Institute. |
| Simone Thomas, Other | Mrs. Thomas has received personal compensation for serving as an employee of Foundation of Peripheral Neuropathy. |
| Ke Xu | Dr. Xu has nothing to disclose. |
| Alrabi Tawil, MD, FAAN | Dr. Tawil has received personal compensation in the range of $500-$4,999 for serving as a Consultant for DYNE Therapeutics. Dr. Tawil has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arrowhead Pharma. Dr. Tawil has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fulcrum Therapeutics. Dr. Tawil has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acceleron Pharma. Dr. Tawil has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MT Pharma. Dr. Tawil has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Pharma. Dr. Tawil has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for miRecule. The institution of Dr. Tawil has received research support from Friends of FSH Research. The institution of Dr. Tawil has received research support from FSH Society. The institution of Dr. Tawil has received research support from NIH. The institution of Dr. Tawil has received research support from Fulcrum. Dr. Tawil has received intellectual property interests from a discovery or technology relating to health care. Dr. Tawil has received publishing royalties from a publication relating to health care. |
| Cristine Charlesworth, PhD | Dr. Charlesworth has nothing to disclose. |
| Victor De Paz Benito | No disclosure on file |
| Ken L. Johnson, Other | Mr. Johnson has received intellectual property interests from a discovery or technology relating to health care. |
| Kiley Higgs | Kiley Higgs has nothing to disclose. |
| Taha Qarni, MD | Dr. Qarni has nothing to disclose. |
| Katy Eichinger, PT,PhD, DPT, NCS | Dr. Eichinger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Fulcrum. Dr. Eichinger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Avidity. Dr. Eichinger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for DyneTherapeutic. Dr. Eichinger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Eichinger has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for FSHD Society. The institution of Dr. Eichinger has received research support from Charcot Marie Tooth Association. |
| Melissa Currence | Melissa Currence has nothing to disclose. |
| Cai Xiaotang | No disclosure on file |
| Seth Friedman | Seth Friedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fulcrum Therapeutics. Seth Friedman has received research support from NIH. |
| John Jiang, PhD | Dr. Jiang has received personal compensation for serving as an employee of Fulcrum Therapeutics. |
| Erin K. O'Ferrall, MD | The institution of Dr. O'Ferrall has received research support from Sanofi Genzyme. The institution of Dr. O'Ferrall has received research support from Harmony Biosciences. The institution of Dr. O'Ferrall has received research support from Fulcrum Therapeutics. The institution of Dr. O'Ferrall has received research support from Roche Pharmaceuticals. Dr. O'Ferrall has received publishing royalties from a publication relating to health care. |
| Araya Puwanant, MD | The institution of Dr. Puwanant has received research support from Muscular Dystrophy Association. The institution of Dr. Puwanant has received research support from NIH/NINDS. The institution of Dr. Puwanant has received research support from NIH/NINDS. |
| Kristina Marie Kelly, PT | Dr. Kelly has nothing to disclose. |
| Nikia Stinson | Nikia Stinson has nothing to disclose. |
| Angela L. Genge, MD | Dr. Genge has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AL-S Pharma. Dr. Genge has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Genge has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Genge has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amylyx. Dr. Genge has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Quralis. Dr. Genge has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Genge has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MTPA. Dr. Genge has received personal compensation in the range of $0-$499 for serving as a Consultant for WAVE. |
| Jason Doles, PhD | Dr. Doles has nothing to disclose. |
| Christy Skura | Christy Skura has nothing to disclose. |
| Maria Chiara Frisoni, PT | Miss Frisoni has nothing to disclose. |
| Pamela W. Duncan, PhD, FAHA, FAPTA | Dr. Duncan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BrainQ Technologies. Dr. Duncan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Pittsburg Pepper Center. Dr. Duncan has stock in CareDirections. The institution of Dr. Duncan has received research support from PCORI. The institution of Dr. Duncan has received research support from NIA and NINDS. The institution of Dr. Duncan has received research support from AHRQ. Dr. Duncan has received intellectual property interests from a discovery or technology relating to health care. |
| Remi Ben-Davies | Mr. Ben-Davies has nothing to disclose. |
| Peter Lawrence Jones, PhD | Dr. Jones has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Fulcrum Therapeutics. Dr. Jones has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fulcrum Therapeutics. Dr. Jones has stock in Fulcrum Therapeutics. Dr. Jones has stock in Renogenyx, Inc. An immediate family member of Dr. Jones has stock in Renogenyx, Inc. The institution of Dr. Jones has received research support from FSHD Canada Research Foundation. The institution of Dr. Jones has received research support from Friends of FSH Research. The institution of Dr. Jones has received research support from The Chris Carrino Foundation for FSHD. The institution of Dr. Jones has received research support from FSHD Global Research Foundation. The institution of Dr. Jones has received research support from The National Institutes of Health. Dr. Jones has received intellectual property interests from a discovery or technology relating to health care. Dr. Jones has received intellectual property interests from a discovery or technology relating to health care. Dr. Jones has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Jones has received intellectual property interests from a discovery or technology relating to health care. |
| Xu Huayan | No disclosure on file |
| Aileen S. Jones, PT | Mrs. Jones has nothing to disclose. |
| Michael McDermott | Michael McDermott has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NeuroDerm, Ltd.. Michael McDermott has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly and Company. Michael McDermott has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catabasis Pharmaceuticals, Inc.. Michael McDermott has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vaccinex, Inc.. Michael McDermott has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurocrine Biosciences, Inc.. Michael McDermott has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prilenia Therapeutics Development, Inc.. Michael McDermott has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ReveraGen BioPharma, Inc.. Michael McDermott has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NS Pharma, Inc.. The institution of Michael McDermott has received research support from NIH. The institution of Michael McDermott has received research support from FDA. The institution of Michael McDermott has received research support from Cure SMA. |
| Felipe Simoes Jones, MD | Dr. Simoes Jones has nothing to disclose. |
| Lindsay Baker, PT | Mrs. Baker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. |
| Pitcha Chompoopong, MD | Dr. Chompoopong has nothing to disclose. |
| Joanita Figueredo | Dr. Figueredo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UsinLife LLC. |
| Stefano Becchiati, PT | Dr. Becchiati has nothing to disclose. |
| Jaya Raghav Trivedi, MD, FAAN | Dr. Trivedi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Trivedi has received research support from NIH. |
| Xu Rong | No disclosure on file |
| John W. Day, MD, PhD | Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Affinia Therapeutics. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis Gene Therapy. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Day has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Day has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Day has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. Dr. Day has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity. Dr. Day has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Muscular Dystrophy Association. The institution of Dr. Day has received research support from Audentes. The institution of Dr. Day has received research support from Novartis Gene Therapy. The institution of Dr. Day has received research support from Biogen. The institution of Dr. Day has received research support from Cytokinetics. The institution of Dr. Day has received research support from Roche/Genentech. The institution of Dr. Day has received research support from Sanofi/Genzyme. The institution of Dr. Day has received research support from Sarepta. The institution of Dr. Day has received research support from Scholar Rock. Dr. Day has received intellectual property interests from a discovery or technology relating to health care. |
| Nikita Jain, MD | Dr. Jain has nothing to disclose. |
| Carolina Burgos-Aguilar, Other | Mrs. Burgos-Aguilar has nothing to disclose. |
| Damien Eggenspieler | Mr. Eggenspieler has received personal compensation in the range of $50,000-$99,999 for serving as a Healthcare director with Sysnav. |
| Dennis W. Shaw, MD | The institution of Dennis W. Shaw, MD has received research support from Friends of FSHD Research. |
| Valeria A. Sansone, MD | Dr. Sansone has nothing to disclose. |
| Ting Xu, MD | Dr. Xu has nothing to disclose. |
| Aneesha Dasgupta, PhD | Dr. Dasgupta has nothing to disclose. |
| Jeremy Garcia, PT | No disclosure on file |
| Karlien Mul | The institution of Karlien Mul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avidity Biosciences. |
| S H. Subramony, MBBS, FAAN | Dr. Subramony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avidity. Dr. Subramony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne. Dr. Subramony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lupin. Dr. Subramony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fallonmedica. The institution of Dr. Subramony has received research support from Reata. The institution of Dr. Subramony has received research support from Retrotope. The institution of Dr. Subramony has received research support from Acceleron. The institution of Dr. Subramony has received research support from Biohaven. The institution of Dr. Subramony has received research support from Pharnext. The institution of Dr. Subramony has received research support from Fulcrum. The institution of Dr. Subramony has received research support from National Ataxia Foundation. The institution of Dr. Subramony has received research support from Friedreich Ataxia Research Alliance. The institution of Dr. Subramony has received research support from Muscular Dystrophy Association. The institution of Dr. Subramony has received research support from Univ of Rochester, MDA. The institution of Dr. Subramony has received research support from Virginia Commonwealth Univ (FDA, Wyck Foundation)). The institution of Dr. Subramony has received research support from Children's Hospital, Philadelphia (FDA). The institution of Dr. Subramony has received research support from Houston Methodist (NIH). The institution of Dr. Subramony has received research support from NIHR01 AR076060-01A1 . The institution of Dr. Subramony has received research support from NIH2R42HD089804-04 . The institution of Dr. Subramony has received research support from NIH R01 AR056973 . The institution of Dr. Subramony has received research support from FSHD Society. The institution of Dr. Subramony has received research support from AAVANTI BIO. The institution of Dr. Subramony has received research support from COHAV FL State Dept of Health. |
| Jennifer *Use 325910 Shoskes, PharmD | Dr. Shoskes has received personal compensation for serving as an employee of Fulcrum Therapeutics. An immediate family member of Dr. Shoskes has received personal compensation for serving as an employee of Exact Science. |
| Carly Jo Olszewski, MD | Dr. Olszewski has nothing to disclose. |
| Sandhya Sasidharan, PT | Dr. Sasidharan has nothing to disclose. |
| Jennifer Shoskes, PharmD | No disclosure on file |
| Mamatha Pasnoor, MD, FAAN | Dr. Pasnoor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx BVBA. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for catalyst. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda Pharmaceuticals. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceutical. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Pasnoor has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for catalyst pharmaceuticals. Dr. Pasnoor has received research support from NIH. |